Skip to content
Life Sciences Series B Founded 2003

Pregene

Provider of reagents and kits for molecular biology research. The product line includes gene expression vectors, protein expression detection and quantification, protein-protein and protein-ligand interactions, antibodies, reporter kits, and assays. Founded in 2003, headquartered in Beijing, China. The company has raised $21.2M in funding at the series b stage. The team comprises 8 (Jun 30, 2026) employees. Backed…

📍 Beijing, China · Genomics,

Funding snapshot

Last roundSeries B
Amount$21M
Date16 November 2020
Total raised$21M
Team size8

About

Provider of reagents and kits for molecular biology research. The product line includes gene expression vectors, protein expression detection and quantification, protein-protein and protein-ligand interactions, antibodies, reporter kits, and assays. Founded in 2003, headquartered in Beijing, China. The company has raised $21.2M in funding at the series b stage. The team comprises 8 (Jun 30, 2026) employees. Backed by investors including Shenzhen Guozhong Venture Capital Management, haierhealth.net, Huapont Life Sciences. The company is tagged with Tech, Enterprise. Pregene is recognized as a minicorn.

Business model

Genomics > Enabling Technologies > Kits and Reagents > Suite,

Life Sciences Platforms and Tools > Research Reagents and Kits > Diversified

Institutional investors

Shenzhen Guozhong Venture Capital Management haierhealth.net Huapont Life Sciences

Latest coverage

No articles yet.

Raising like Pregene?

Analyze your pitch deck before your next raise.

Analyze My Deck →